VCN-01 Demonstrates Early Efficacy, Safety in Pediatric Refractory Retinoblastoma
VCN-01 was safe and elicited signs of antitumor activity in patients with intraocular retinoblastoma that was refractory to chemotherapy or radiotherapy.
Source: onclive.com